Muutke küpsiste eelistusi

Nutrition in the Prevention and Treatment of Abdominal Obesity 2nd edition [Pehme köide]

Edited by (Professor, Mel and Enid Zuckerman College of Public Health and School of Medicine, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA)
  • Formaat: Paperback / softback, 522 pages, kõrgus x laius: 235x191 mm, kaal: 970 g
  • Ilmumisaeg: 28-Nov-2018
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0128160934
  • ISBN-13: 9780128160930
Teised raamatud teemal:
  • Formaat: Paperback / softback, 522 pages, kõrgus x laius: 235x191 mm, kaal: 970 g
  • Ilmumisaeg: 28-Nov-2018
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0128160934
  • ISBN-13: 9780128160930
Teised raamatud teemal:

Nutrition in the Prevention and Treatment of Abdominal Obesity, Second Edition focuses on the important role that exercise, dietary changes and foods play in promoting and reducing visceral fat. Nutritionists, dieticians and healthcare providers seeking to address the abdominal obesity epidemic will find this book to be a valuable resource in their long-term goal of preventing chronic diseases, especially heart, vascular and diabetic diseases. Chapters define a range of dietary approaches to reduce risk for the associated chronic diseases. In addition, discussions of the importance of dietary approaches to reduce abdominal obesity, along with clinical approaches, are discussed, including costs and risks.

  • Serves as a starting point for in-depth discussions in academic settings that will lead to revised and updated treatment options
  • Offers detailed, well-documented reviews outlining the various dietary approaches to visceral obesity with their benefits and failures
  • Includes updated research on the gut microbiome, FGF 21 and dietary foods and supplements
Contributors xi
Acknowledgments xvii
I Overview Of Obesity And Population Studies
1 Sleep, Abdominal Obesity, and Metabolic Syndrome
Chris I. Ardern
Thirumagal Kanagasabai
Introduction
3(1)
Descriptive Epidemiology of Sleep, Obesity, and Cardiometabolic Diseases
4(7)
Potential Mechanisms
11(2)
Future Directions
13(1)
References
14(5)
2 The New Anthropometrics and Abdominal Obesity: A Body Shape Index, Hip Index, and Anthropometric Risk Index
Nir Y. Krakauer
Jesse C. Krakauer
Introduction
19(1)
Basic Anthropometrics and Abdominal Obesity
20(1)
The New Anthropometrics
21(2)
Discussion
23(1)
Conclusion
24(1)
Acknowledgments
24(1)
References
24(5)
3 Comparing Measures of Obesity: Waist Circumference, Waist-Hip, and Waist-Height Ratios
Alaa Youssef Ahmed Ahmed Baioumi
Introduction
29(1)
Obesity and the Pattern of Fat Distribution Is a Central Mechanism in the Development of Obesity Comorbidities
30(1)
Metabolic Syndrome Definition and Relation to Fat Accumulation
31(1)
Is There a Healthy Obese Phenotype?
32(1)
Clinical Measures of Adiposity and Fat Distribution
32(1)
Body Mass Index
32(1)
Waist Circumference
33(1)
Waist-Hip Ratio
34(1)
Waist-Height Ratio
35(1)
Direct Measurement of Body Fat Distribution
35(2)
References
37(3)
Further Reading
40(1)
4 Abdominal Obesity and the Interaction Between Adipocytes and Osteoblasts
Greco Emanuela A
Marocco Chiara
Mocini Edoardo
Lenzi Andrea
Migliaccio Silvia
Introduction
41(1)
Visceral Adipose Tissue and Adipokine Action on Bone Health
42(4)
The Common Origin of Adipocytes and Osteoblasts
46(1)
Conclusion
47(1)
References
47(35)
Introduction
82(1)
Abdominal Obesity in Children
82(9)
Conclusion
91(1)
References
91
5 Pharmacologic Agents
Chapter for Abdominal Obesity
Wesley Nuffer
Introduction
51(1)
History of Pharmacologic Agents for Obesity
52(1)
Current Pharmacologic Agents for the Treatment of Obesity
53(1)
Phentermine
54(1)
Orlistat
55(1)
Lorcaserin
56(2)
Phentermine/Topiramate Extended Release
58(1)
Naltrexone/Bupropion Sustained Release
59(2)
Liraglutide
61(1)
Place in Therapy for Antiobesity Prescription Drugs
62(2)
Conclusion
64(1)
References
64(3)
6 Sleeve Gastrectomy for Morbid Obesity: Technique and Outcomes
Federico Serrot
Emanuele Lo Menzo
Samuel Szomstein
Raul J. Rosenthal
Introduction
67(1)
Technique
68(1)
Postoperative Care
68(1)
Outcomes
69(1)
Conclusions
70(1)
References
70(3)
7 Waist Circumference: Measures and Applications to Obesity
Richard Buendia
Monica Zambrano
Andres Ricardo Buendia Jaime
Raquel Ramirez
Alfonso Kerguelen
Introduction
73(1)
Measures
74(1)
Applications to Obesity
75(2)
Conclusion
77(1)
References
77(5)
8 Abdominal Obesity in Children: The Role of Physical Activity, Sedentary Behavior, and Sleep Time
Marcus Vinicius Nascimento-Ferreira
Tara Rendo-Urteaga
Augusto Cesar Ferreira De Moraes
Luis A. Moreno
Heraclito Barbosa Carvalho
Introduction
82(1)
Abdominal Obesity in Children
82(9)
Conclusion
91(1)
References
91(5)
9 The Concept of a Web-Based Calculator for Supporting Waist Circumference Interpretation Among Pediatric Patients
T. Nawarycz
K. Pytel
L. Ostrowska-Nawarycz
Waist Circumference-Based Indicators in Pediatric Subjects: Importance in Diagnostics and Monitoring of Obesity Complications
96(1)
Internet-Based Technology Supporting the Interpretation of WC and Body Composition in Pediatric Subjects: Examples of Solutions
97(1)
Web-Based Calculator for Supporting WC Interpretation Among Pediatric Patients: Own Concepts
98(3)
Summary and Perspectives
101(2)
References
103(4)
10 Remission of Metabolic Syndrome After Sleeve Gastrectomy
Jaime Ruiz-Tovar
Carolina Llavero
Introduction
107(1)
Effect of SG on Type 2 Diabetes Mellitus
108(1)
Effect of SG on Lipid Profile
109(1)
Effect of SG on Hypertension
109(1)
Conclusion
110(1)
References
110(1)
Further Reading
111(7)
11 Nutrients and Obesity
Mariana Sarto Figueiredo
Jean Francisco Vettorazzi
Renato Chaves Souto Branco
Everardo Magalhaes Carneiro
References
118(5)
12 The Role of Physical Activity in Adult Obesity
Alessandro Ilacqua
Gian Pietro Emerenziani
Laura Guidetti
Carlo Baldari
Introduction
123(1)
Defining PA and Physical Fitness
124(1)
Effects of PA on Obese and Obese Diabetic Population
124(3)
References
127(5)
II Mechanisms Of Obesity
13 Fibroblast Growth Factor 21 as a Regulator of Energy Metabolism in the Liver and Adipose Tissue
Niina Matikainen
Sanni Soderlund
Background
132(1)
Structure, Expression Sites, and Receptor Binding of FGF21
132(1)
Paracrine/Autocrine, Endocrine, and Pharmacological Roles of FGF21
133(1)
Production and Regulation of FGF21 Expression
133(3)
Physiological Role of FGF21
136(5)
The Role of FGF21 in Human Metabolic Diseases
141(2)
FGF21-Targeted Therapy
143(4)
References
147(6)
14 Genetics of Central Obesity and Body Fat
Yoriko Heianza
Lu Qi
Introduction
153(1)
Heritability
154(1)
Monogenic Obesity
155(1)
Genome-Wide Linkage Study
155(1)
Candidate-Gene Association Study
156(1)
Genome-Wide Association Study
157(7)
Gene-Environment Interactions
164(2)
Sexual Dimorphism
166(1)
Epigenetics
167(1)
Conclusions
167(1)
References
168(7)
15 Stress-Induced Eating Dampens Physiological and Behavioral Stress Responses
Laura E. Finch
Lauren Tiongco-Hofschneider
A. Janet Tomiyama
Introduction
175(2)
Glucocorticoids and Insulin Promote Stress-Induced Eating
177(1)
Glucocorticoids and Insulin Promote Visceral Fat Accumulation
177(1)
Stress-Induced Eating Dampens Physiological and Behavioral Stress Responses
178(2)
Reinforcement of Stress-Induced Eating Via Affective Responses, the Reward System, and Enhanced Memory
180(1)
Role of Glucocorticoids and Visceral Fat in Dampening Stress Responses
181(2)
Conclusion and Future Directions
183(1)
References
184(6)
16 An Emerging Role of the Angiotensin Receptor Binding Protein ATRAP as a Possible Novel Player in the Pathophysiology of Visceral Obesity and Metabolic Disorders
Hiromichi Wakui
Kengo Azushima
Kohji Ohki
Kazushi Uneda
Ryu Kobayashi
Toru Suzuki
Kouichi Tamura
Renin-Angiotensin System and Visceral Obesity
190(2)
Identification of ATRAP
192(1)
The Function of ATRAP in Cardiovascular Cells and Tissues
193(2)
Decreased ATRAP Expression in Adipose Tissue in Metabolic Disorders
195(2)
ATRAP Deficiency Exacerbates Metabolic Disorders
197(2)
ATRAP Enhancement Improves Metabolic Disorders
199(6)
Conclusion
205(1)
References
206(5)
17 Ethnicity and Cut-Off Values in Obesity
Ejiroghene Martha Umuerri
Introduction
211(1)
Ethnicity and Perception of Obesity
212(1)
Definition and Measurement of Obesity:
Historical Perspective
212(2)
Cut-Off Values for BMI
214(1)
Ethnic-Specific BMI Cut-Off Values
215(2)
Cut-off Values for Abdominal Obesity
217(1)
Waist-Hip Ratio
217(1)
Waist Circumference
217(1)
Waist-to-Height Ratio
218(1)
Ethnicity and Central Obesity Cut-Off Values
218(2)
References
220(8)
III Role Of Dietary Supplements In Obesity
18 Regulation of the Energy Balance
Eduardo Emanuel Satiro Vieira
Natalia Da Silva Lima
Emidio Marques De Matos-Neto
Francisco Leonardo Torres-Leal
Introduction
228(1)
Concepts of the Energy Homeostasis
228(1)
Basal Metabolic Rate
229(1)
Central Hypothalamic Regulation of Energy Balance
230(3)
Regulation of Short-Term Food Intake by Peripheral Signals
233(1)
Regulation of Long-Term Food Intake by Peripheral Signals
234(1)
Effects of Diet on Adaptative Thermogenesis
235(1)
Locomotor Activity and Energy Balance
236(2)
Conclusion
238(1)
References
239(6)
19 Using Psyllium to Prevent and Treat Obesity Comorbidities
Sebely Pal
Jenny McKay
Monica Jane
Suleen Ho
Introduction
245(1)
Psyllium and Health
246(1)
Body Composition and Appetite
247(2)
Blood Sugar Levels and Insulin Regulation
249(1)
Blood Lipids
250(3)
Vascular Function
253(2)
Conclusion
255(1)
Acknowledgments
255(1)
References
256(5)
20 Dairy Whey Proteins and Obesity
Sebely Pal
Jenny Mckay
Monica Jane
Suleen Ho
Introduction
261(2)
Appetite and Satiety
263(3)
Glucose and Insulin Concentrations
266(2)
Body Composition
268(1)
Blood Lipids
269(2)
Blood Pressure
271(1)
Vascular Function
272(1)
Conclusion
273(1)
Acknowledgments
274(1)
References
274(7)
IV Foods And Macronutrients In Obesity
21 The Mediterranean Diet: What It Is and Its Effect on Abdominal Obesity
Emmanuella Magriplis
Eleni Andreou
Antonis Zampelas
Defining Abdominal Obesity
281(1)
Body Composition and Abdominal Obesity
282(1)
The Concept of the Mediterranean Diet
283(1)
The New Model of Mediterranean Diet
284(5)
Abdominal Obesity and the Mediterranean Diet in Childhood
289(1)
Evaluating MD Adherence in Children
290(2)
Obesity and Abdominal Fat and Mediterranean Diet in Adulthood
292(4)
Conclusion
296(1)
References
296(5)
22 International Aspects: Abdominal Obesity in Greece
Maria G. Grammatikopoulou
Xenophon Theodoridis
Michael Chourdakis
Introduction
301(1)
Historical Perspective and Epigenetic Exposure Timeline
302(2)
Geography of Obesity
304(1)
Prevalence of AO in Greece
304(6)
Familiar Environment and AO Among Greeks
310(1)
Prenatal Exposure and Epigenetics of AO in Greece
310(1)
Dietary Pattern and AO in Greece
311(1)
Physical Activity and AO Among Greeks
312(1)
Overview and Implications
312(1)
References
313(4)
23 Artificial Sweeteners: Implications for Weight Loss in Obesity
Hugo Laviada-Molina
Fernanda Molina-Segui
Reinhard Janssen-Aguilar
General Considerations
317(1)
AS Role in Obesity Management and Comorbidities
318(7)
Diabetes and Other Conditions Related to Obesity
325(1)
References
325(3)
Further Reading
328(1)
24 Coffee Intake and obesity
Gustavo D. Pimentel
Thayana O. Micheletti
Renata C. Fernandes
Astrid Nehlig
Obesity, Coffee Consumption, and Its Compounds
329(1)
Coffee and Reduction of Obesity Risk: A Vision From Epidemiological Studies
330(3)
Coffee and Its Components
333(2)
Coffee and the Mechanisms That Underlie the Protective Effects Against Obesity
335(9)
Potential Adverse Effects of Coffee
344(2)
Conclusion
346(1)
References
346(9)
V Micronutrients And Dietary Components In Obesity
25 Conjugated Linoleic Acid in Human Health: Effects on Weight Control
Phoebe B. Chen
Yeonhwa Park
Introduction
355(1)
Discovery and Origins of CLA
356(1)
Antiobeisty Effects of CLA
357(11)
Other Health Benefits of CLA
368(4)
Conclusion
372(1)
References
372(11)
26 Serum Magnesium and Abdominal Obesity and Its Consequences
Teresa Kokot
Ewa Malczyk
Katarzyna Wilemska-Kucharzewska
Malgorzata Muc-Wierzgon
Edyta Fatyga
Introduction
383(1)
Magnesium Deficiency and Its Health-Associated Consequences
384(2)
Abdominal Obesity
386(1)
Mechanism Magnesium Deficiency in Obesity
387(1)
Magnesium and Abdominal Obesity
388(1)
Conclusion
389(1)
References
390(3)
27 Integrative Health and Medicine: Dietary Supplements and Modalities for the Treatment of Obesity
Monika Nuffer
Introduction
393(1)
IHM Modalities
394(1)
Use of IHM
395(1)
IHM and Scientific Evidence
395(1)
IHM Evidence Outside of the Biologically Based Domain
396(2)
Biologically Based Systems
398(1)
Digestive Inhibitors
398(2)
Thermogenic Agents
400(2)
Appetite Suppressants
402(1)
Miscellaneous Agents
403(2)
Conclusions
405(1)
References
405(4)
28 Anthocyanins: What They Are and How They Relate to Obesity Prevention
Inhae Kang
Yunkyoung Lee
Myoungsook Lee
Anthocyanins
409(2)
How Anthocyanins Relate to Obesity
Prevention
411(14)
Conclusions and Future Research Perspectives
425(1)
References
425(6)
29 The Positive Effects of Olive Oil Toward Lipotoxicity and Obesity
Samantha Bell
Lipotoxicity
431(1)
Obesity
432(1)
What Makes Olive Oil So Advantageous Toward Health?
433(1)
The Benefits of Olive Oil versus Coconut Oil and Others
433(1)
Conclusion: The Positive Effects of Olive Oil Toward Lipotoxicity and Obesity
434(1)
References
434(3)
30 Effects of Diet-Induced Early-Stage Obesity on a Low-Testosterone Gottingen Minipig
I. Diaz-Guemes Martin-Portugues
L. Hernandez Hurtado
J.L. De La Cruz Vigo
A.M. Matos-Azevedo
V. Alvarez Perez
F.M. Sanchez-Margallo
Introduction
437(2)
Materials and Methods
439(2)
Results
441(3)
Discussion
444(3)
Acknowledgments
447(1)
Author Contributions
447(1)
References
447(2)
31 The Effects of Fiber on Visceral Fat
Yoona Kim
Introduction
449(1)
Visceral Fat
450(1)
The Epidemiology of Abdominal Obesity
451(2)
Brief Research History and Physiochemistry of Fiber
453(1)
Dietary Fiber Consumption
454(1)
Benefits of Fiber on General Health
454(1)
Relationship Between Fiber and Visceral Fat
455(1)
Conclusion
456(1)
Acknowledgments
456(1)
References
456(3)
32 Carotenoids as a Nutraceutical Therapy for Visceral Obesity
Kazuo Miyashita
Masashi Hosokawa
Introduction
459(2)
Carotenoids
461(11)
Conclusion
472(1)
References
472(5)
Further Reading
477(3)
33 Laparoscopic Adjustable Gastric Banding (LAGB) as a Bariatric Procedure
David Gutierrez-Blanco
Kandace Kichler
Emanuele Lo Menzo
Samuel Szomstein
Raul J. Rosenthal
Introduction
480(1)
History
480(2)
Technique
482(1)
Results and Weight Loss Outcomes
482(1)
Complications
483(2)
Reoperation and Conversions
485(1)
Current Status
486(1)
Future of LAGB
487(1)
Conclusions
487(1)
Disclosure
487(1)
References
487(2)
Further Reading
489(2)
Index 491
Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watsons career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models.